AzTrials
AzTrials

Primary Inguinal HerniaNCT01596049

The Efficacy of a Self-fixating Mesh in Unilateral Open Inguinal Hernia Repair

An observational study of Primary Inguinal Hernia and Unilateral Hernia, run by Rambam Health Care Campus at 1 site in Israel.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

This study's objective is to assess the efficacy of a Self-fixating mesh in the surgical repair of unilateral inguinal hernia, which is becoming the new standard of care in open surgical repair of inguinal hernia. Read more about this study

Who is it for?
Ages 18 to 90 years, men only
What is being tested?
Self-fixating Mesh
Type of treatment
Medical device
How many people
7 participants
Where
1 siteIsrael
Study dates
May 2012to Aug 2017
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 90 years
  • Men only
  • No healthy volunteers
  • Adult, Older adult

Study population: patients who are undergoing Inguinal Hernia Repair Surgery.

Who may be able to join

  • All patients undergoing primary unilateral open Inguinal Hernia Repair .
  • patients undergoing elective surgery.
  • above the age of 18 years old

Who cannot join

  • patients having repeated Inguinal Hernia.
  • patients having bilateral Hernia.
  • patients undergoing laparoscopic surgery.
  • patients undergoing non-elective surgery.

Trial locations and contacts

1 site in 1 country.

Israel1 site
  • Rambam health care campus

    Haifa

Other trials in Israel

About this study

Official title: The Efficacy of a Self-fixating Mesh in Unilateral Open Inguinal Hernia Repair, in Comparison to the Standard Treatment in the Literature

This study's objective is to assess the efficacy of a Self-fixating mesh in the surgical repair of unilateral inguinal hernia, which is becoming the new standard of care in open surgical repair of inguinal hernia.

The study design is interventional, enrolling 300 patients above 18 years of age, admitted for elective repair in the surgical department of Rambam Medical Health Care Campus, an academic medical center.

The study will assess several outcomes including post-surgical pain, recurrence, quality of life and post surgical complications (e.g. wound infection, the formation of hematoma or seroma, etc).

Read the detailed description

This study's objective is to assess the efficacy of a Self-fixating mesh in the surgical repair of unilateral inguinal hernia, which is becoming the new standard of care in open surgical repair of inguinal hernia.

The study design is interventional, enrolling 300 patients above 18 years of age, admitted for elective repair in the surgical department of Rambam Medical Health Care Campus, an academic medical center.

The study will assess several outcomes including post-surgical pain, recurrence, quality of life and post surgical complications (e.g. wound infection, the formation of hematoma or seroma, etc).

The data will be compared to the literature and will be statistically analysed. The follow-up for each patient will be two years.

Being tested
Self-fixating Mesh

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Self-fixating MeshDevice

    Using Self-fixating Mesh for Inguinal Hernia Repair

Study groups in NCT01596049
Study groupRoleWhat they receive
Self-fixating Meshpatients attributed to that arm, undergoing surgery of open inguinal unilateral hernia repair, using Self-fixating Mesh which is acceptable in the literature.
Receives: Device: Self-fixating Mesh

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Percentage of post operative inguinal Hernia recurrence.

    Measured: 2 weeks, 3,6,12,24 months post-operative

  2. Post-operative patient quality of life will be assessed using a validated questionnaire.

    Measured: 2 weeks, 3,6,12,24 months post-operative

  3. Pain will be assessed by NRS (Numerical Rating Scale)

    Measured: 2 weeks, 3,6,12,24 months post-operative

  4. Post-operative complications will be assessed using a validated questionnaire.

    Measured: 2 weeks, 3,6,12,24 months post-operative

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 May 2012 (estimated)
  2. Study startMay 2012
  3. Primary completionAug 2017
  4. Study completionAug 2017

Why it stopped: recruitment was not going well.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
7 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01596049
Sponsor's protocol ID
hernia313-11-RMBCTIL
Status last verified
Aug 2017
First submitted
9 May 2012
Last updated
22 Aug 2017
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Primary Inguinal Hernia and Unilateral Hernia, run by Rambam Health Care Campus at 1 site in Israel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 22 Aug 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: recruitment was not going well.). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Percentage of post operative inguinal Hernia recurrence. (time frame: 2 weeks, 3,6,12,24 months post-operative). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Aug 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in